Switch to:
More From Other Websites
ETFs with exposure to Halozyme Therapeutics, Inc. : March 6, 2017 Mar 06 2017
HALOZYME THERAPEUTICS INC Financials Mar 04 2017
Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017 Mar 02 2017
Edited Transcript of HALO earnings conference call or presentation 28-Feb-17 9:30pm GMT Mar 01 2017
HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition Feb 28 2017
HALOZYME THERAPEUTICS INC Files SEC form 10-K, Annual Report Feb 28 2017
Halozyme Therapeutics reports 4Q loss Feb 28 2017
Halozyme Therapeutics reports 4Q loss Feb 28 2017
4:10 pm Halozyme Therapeutics beats by $0.09, beats on revs; reaffirms FY17 revs guidance Feb 28 2017
Halozyme Reports Fourth Quarter And Full Year 2016 Financial Results Feb 28 2017
Q4 2016 Halozyme Therapeutics Inc Earnings Release - After Market Close Feb 28 2017
Why Halozyme Therapeutics (HALO) Might Surprise This Earnings Season Feb 27 2017
Halozyme Therapeutics To Present At Upcoming Healthcare Conferences Feb 23 2017
MabVax Therapeutics Studies Lead Investigational Drug MVT-5873 with Halozyme PEGPH20 Feb 13 2017
Halozyme To Host Fourth Quarter 2016 Financial Results Conference Call Feb 01 2017
Halozyme Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HALO-US :... Jan 27 2017
ETFs with exposure to Halozyme Therapeutics, Inc. : January 17, 2017 Jan 17 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK